Evaluation of Event-Free Survival as a Surrogate Endpoint for Overall Survival in Muscle-Invasive Bladder Cancer Following Neoadjuvant Treatment: A Systematic Review and Meta-Analysis

Abstract Introduction Event-free survival (EFS), a common endpoint in neoadjuvant/perioperative oncology trials, allows for accelerated treatment evaluation while awaiting results of overall survival (OS). However, the surrogacy of EFS for OS in muscle-invasive bladder cancer (MIBC) has yet to be es...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cora N. Sternberg, Patrick Squires, Yan Song, Aozhou Wu, Yipeng Gao, Ritesh S. Kataria, Haojie Li
Format:	Artigo
Idioma:	Inglês
Publicat:	Adis, Springer Healthcare 2025-11-01
Col·lecció:	Oncology and Therapy
Matèries:	Muscle-invasive bladder cancer Neoadjuvant treatment Event-free survival Overall survival Surrogate endpoints
Accés en línia:	https://doi.org/10.1007/s40487-025-00399-3
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!